Literature DB >> 25382417

Identification of recurrent truncated DDX3X mutations in chronic lymphocytic leukaemia.

Juhi Ojha1, Charla R Secreto, Kari G Rabe, Daniel L Van Dyke, Klaus M Kortum, Susan L Slager, Tait D Shanafelt, Rafael Fonseca, Neil E Kay, Esteban Braggio.   

Abstract

Entities:  

Keywords:  DDX3X; chronic lymphocytic leukaemia; genomics; targeted sequencing; tumour suppressor gene

Mesh：

Substances：

Year:  2014        PMID： 25382417      PMCID： PMC4865407          DOI： 10.1111/bjh.13211

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  10 in total

1.  Disruption of BIRC3 associates with fludarabine chemorefractoriness in TP53 wild-type chronic lymphocytic leukemia.

Authors:  Davide Rossi; Marco Fangazio; Silvia Rasi; Tiziana Vaisitti; Sara Monti; Stefania Cresta; Sabina Chiaretti; Ilaria Del Giudice; Giulia Fabbri; Alessio Bruscaggin; Valeria Spina; Clara Deambrogi; Marilisa Marinelli; Rosella Famà; Mariangela Greco; Giulia Daniele; Francesco Forconi; Valter Gattei; Francesco Bertoni; Silvia Deaglio; Laura Pasqualucci; Anna Guarini; Riccardo Dalla-Favera; Robin Foà; Gianluca Gaidano
Journal:  Blood       Date:  2012-02-03       Impact factor: 22.113

2.  Combination chemoimmunotherapy with pentostatin, cyclophosphamide, and rituximab shows significant clinical activity with low accompanying toxicity in previously untreated B chronic lymphocytic leukemia.

Authors:  Neil E Kay; Susan M Geyer; Timothy G Call; Tait D Shanafelt; Clive S Zent; Diane F Jelinek; Renee Tschumper; Nancy D Bone; Gordon W Dewald; Thomas S Lin; Nyla A Heerema; Lisa Smith; Michael R Grever; John C Byrd
Journal:  Blood       Date:  2006-09-28       Impact factor: 22.113

3.  Integrated mutational and cytogenetic analysis identifies new prognostic subgroups in chronic lymphocytic leukemia.

Authors:  Davide Rossi; Silvia Rasi; Valeria Spina; Alessio Bruscaggin; Sara Monti; Carmela Ciardullo; Clara Deambrogi; Hossein Khiabanian; Roberto Serra; Francesco Bertoni; Francesco Forconi; Luca Laurenti; Roberto Marasca; Michele Dal-Bo; Francesca Maria Rossi; Pietro Bulian; Josep Nomdedeu; Giovanni Del Poeta; Valter Gattei; Laura Pasqualucci; Raul Rabadan; Robin Foà; Riccardo Dalla-Favera; Gianluca Gaidano
Journal:  Blood       Date:  2012-12-13       Impact factor: 22.113

4.  Longitudinal genome-wide analysis of patients with chronic lymphocytic leukemia reveals complex evolution of clonal architecture at disease progression and at the time of relapse.

Authors:  E Braggio; N E Kay; S VanWier; R C Tschumper; S Smoley; J E Eckel-Passow; T Sassoon; M Barrett; D L Van Dyke; J C Byrd; D F Jelinek; T D Shanafelt; R Fonseca
Journal:  Leukemia       Date:  2012-01-20       Impact factor: 11.528

5.  Evolution and impact of subclonal mutations in chronic lymphocytic leukemia.

Authors:  Dan A Landau; Scott L Carter; Petar Stojanov; Aaron McKenna; Kristen Stevenson; Michael S Lawrence; Carrie Sougnez; Chip Stewart; Andrey Sivachenko; Lili Wang; Youzhong Wan; Wandi Zhang; Sachet A Shukla; Alexander Vartanov; Stacey M Fernandes; Gordon Saksena; Kristian Cibulskis; Bethany Tesar; Stacey Gabriel; Nir Hacohen; Matthew Meyerson; Eric S Lander; Donna Neuberg; Jennifer R Brown; Gad Getz; Catherine J Wu
Journal:  Cell       Date:  2013-02-14       Impact factor: 41.582

6.  Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia.

Authors:  Víctor Quesada; Laura Conde; Neus Villamor; Gonzalo R Ordóñez; Pedro Jares; Laia Bassaganyas; Andrew J Ramsay; Sílvia Beà; Magda Pinyol; Alejandra Martínez-Trillos; Mónica López-Guerra; Dolors Colomer; Alba Navarro; Tycho Baumann; Marta Aymerich; María Rozman; Julio Delgado; Eva Giné; Jesús M Hernández; Marcos González-Díaz; Diana A Puente; Gloria Velasco; José M P Freije; José M C Tubío; Romina Royo; Josep L Gelpí; Modesto Orozco; David G Pisano; Jorge Zamora; Miguel Vázquez; Alfonso Valencia; Heinz Himmelbauer; Mónica Bayés; Simon Heath; Marta Gut; Ivo Gut; Xavier Estivill; Armando López-Guillermo; Xose S Puente; Elías Campo; Carlos López-Otín
Journal:  Nat Genet       Date:  2011-12-11       Impact factor: 38.330

7.  DDX3 loss by p53 inactivation promotes tumor malignancy via the MDM2/Slug/E-cadherin pathway and poor patient outcome in non-small-cell lung cancer.

Authors:  D-W Wu; M-C Lee; J Wang; C-Y Chen; Y-W Cheng; H Lee
Journal:  Oncogene       Date:  2013-04-15       Impact factor: 9.867

8.  Monoclonal B-cell lymphocytosis is characterized by mutations in CLL putative driver genes and clonal heterogeneity many years before disease progression.

Authors:  J Ojha; C Secreto; K Rabe; J Ayres-Silva; R Tschumper; D V Dyke; S Slager; R Fonseca; T Shanafelt; N Kay; E Braggio
Journal:  Leukemia       Date:  2014-07-18       Impact factor: 11.528

9.  Monitoring chronic lymphocytic leukemia progression by whole genome sequencing reveals heterogeneous clonal evolution patterns.

Authors:  Anna Schuh; Jennifer Becq; Sean Humphray; Adrian Alexa; Adam Burns; Ruth Clifford; Stephan M Feller; Russell Grocock; Shirley Henderson; Irina Khrebtukova; Zoya Kingsbury; Shujun Luo; David McBride; Lisa Murray; Toshi Menju; Adele Timbs; Mark Ross; Jenny Taylor; David Bentley
Journal:  Blood       Date:  2012-08-22       Impact factor: 22.113

10.  Medulloblastoma exome sequencing uncovers subtype-specific somatic mutations.

Authors:  Trevor J Pugh; Shyamal Dilhan Weeraratne; Tenley C Archer; Daniel A Pomeranz Krummel; Daniel Auclair; James Bochicchio; Mauricio O Carneiro; Scott L Carter; Kristian Cibulskis; Rachel L Erlich; Heidi Greulich; Michael S Lawrence; Niall J Lennon; Aaron McKenna; James Meldrim; Alex H Ramos; Michael G Ross; Carsten Russ; Erica Shefler; Andrey Sivachenko; Brian Sogoloff; Petar Stojanov; Pablo Tamayo; Jill P Mesirov; Vladimir Amani; Natalia Teider; Soma Sengupta; Jessica Pierre Francois; Paul A Northcott; Michael D Taylor; Furong Yu; Gerald R Crabtree; Amanda G Kautzman; Stacey B Gabriel; Gad Getz; Natalie Jäger; David T W Jones; Peter Lichter; Stefan M Pfister; Thomas M Roberts; Matthew Meyerson; Scott L Pomeroy; Yoon-Jae Cho
Journal:  Nature       Date:  2012-08-02       Impact factor: 49.962
  10 in total
  22 in total

Review 1.  The molecular pathogenesis of chronic lymphocytic leukaemia.

Authors:  Giulia Fabbri; Riccardo Dalla-Favera
Journal:  Nat Rev Cancer       Date:  2016-03       Impact factor: 60.716

Review 2.  Molecular pathogenesis of CLL and its evolution.

Authors:  David Rodríguez; Gabriel Bretones; Javier R Arango; Víctor Valdespino; Elías Campo; Víctor Quesada; Carlos López-Otín
Journal:  Int J Hematol       Date:  2015-01-29       Impact factor: 2.490

3.  Analog sensitive chemical inhibition of the DEAD-box protein DDX3.

Authors:  Stephen N Floor; Krister J Barkovich; Kendall J Condon; Kevan M Shokat; Jennifer A Doudna
Journal:  Protein Sci       Date:  2015-12-26       Impact factor: 6.725

4.  Tumor mutational load predicts time to first treatment in chronic lymphocytic leukemia (CLL) and monoclonal B-cell lymphocytosis beyond the CLL international prognostic index.

Authors:  Geffen Kleinstern; Daniel R O'Brien; Xing Li; Shulan Tian; Brian F Kabat; Kari G Rabe; Aaron D Norman; Huihuang Yan; Celine M Vachon; Nicholas J Boddicker; Timothy G Call; Sameer A Parikh; Laura Bruins; Cecilia Bonolo de Campos; Jose F Leis; Tait D Shanafelt; Wei Ding; James R Cerhan; Neil E Kay; Susan L Slager; Esteban Braggio
Journal:  Am J Hematol       Date:  2020-05-07       Impact factor: 10.047

Review 5.  The DEAD-box protein family of RNA helicases: sentinels for a myriad of cellular functions with emerging roles in tumorigenesis.

Authors:  Mohamed A M Ali
Journal:  Int J Clin Oncol       Date:  2021-03-03       Impact factor: 3.402

Review 6.  Medulloblastoma: Molecular Classification-Based Personal Therapeutics.

Authors:  Tenley C Archer; Elizabeth L Mahoney; Scott L Pomeroy
Journal:  Neurotherapeutics       Date:  2017-04       Impact factor: 7.620

7.  Exome sequencing identifies somatic mutations of DDX3X in natural killer/T-cell lymphoma.

Authors:  Lu Jiang; Zhao-Hui Gu; Zi-Xun Yan; Xia Zhao; Yin-Yin Xie; Zi-Guan Zhang; Chun-Ming Pan; Yuan Hu; Chang-Ping Cai; Ying Dong; Jin-Yan Huang; Li Wang; Yang Shen; Guoyu Meng; Jian-Feng Zhou; Jian-Da Hu; Jin-Fen Wang; Yuan-Hua Liu; Lin-Hua Yang; Feng Zhang; Jian-Min Wang; Zhao Wang; Zhi-Gang Peng; Fang-Yuan Chen; Zi-Min Sun; Hao Ding; Ju-Mei Shi; Jian Hou; Jin-Song Yan; Jing-Yi Shi; Lan Xu; Yang Li; Jing Lu; Zhong Zheng; Wen Xue; Wei-Li Zhao; Zhu Chen; Sai-Juan Chen
Journal:  Nat Genet       Date:  2015-07-20       Impact factor: 38.330

8.  Autoinhibitory Interdomain Interactions and Subfamily-specific Extensions Redefine the Catalytic Core of the Human DEAD-box Protein DDX3.

Authors:  Stephen N Floor; Kendall J Condon; Deepak Sharma; Eckhard Jankowsky; Jennifer A Doudna
Journal:  J Biol Chem       Date:  2015-11-23       Impact factor: 5.157

Review 9.  Multifunctional DDX3: dual roles in various cancer development and its related signaling pathways.

Authors:  Luqing Zhao; Yitao Mao; Jianhua Zhou; Yuelong Zhao; Ya Cao; Xiang Chen
Journal:  Am J Cancer Res       Date:  2016-01-15       Impact factor: 6.166

10.  RNA helicase, DDX3X, is actively recruited to sites of DNA damage in live cells.

Authors:  Michael J Cargill; Alicia Morales; Shashidhar Ravishankar; Edus H Warren
Journal:  DNA Repair (Amst)       Date:  2021-05-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.